Impact of coasting in patients undergoing controlled ovarian stimulation with the gonadotropin-releasing hormone antagonist cetrorelix

Fertility and Sterility

Volumn 85, Issue 5, 2006, Pages 1523-1525

  Bahceci, Mustafa ^a   Ulug, Ulun ^a   Tosun, Suleyman ^a   Erden, Halit Firat ^a   Bayazit, Numan ^a  

^a German Hospital in Istanbul   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; GONADORELIN ANTAGONIST;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; OUTCOME ASSESSMENT; OVARY CYCLE; OVARY HYPERSTIMULATION; PRIORITY JOURNAL;

ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY, FEMALE; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; TREATMENT OUTCOME;

EID: 33646083946     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.10.037     Document Type: Article

References (18)

1. Aboulghar M. Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS. Hum Reprod 18 (2003) 1140-1141
2. Delvigne A., and Rozenberg S. Preventive attitude of physicians to avoid OHSS in IVF patients. Hum Reprod 16 (2001) 2491-2495
3. Ulug U., Ben-Shlomo I., and Bahceci M. Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian stimulation for assisted conception. Fertil Steril 82 (2004) 338-342
4. Levinsohn-Tavor O., Friedler S., Schachter M., Raziel A., Strassburger D., and Ron-El R. Coasting-what is the best formula?. Hum Reprod 18 (2003) 937-940
5. Bahceci M., Ulug U., Ben-Shlomo I., Erden H.F., and Akman M.A. Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease. a randomized, prospective, pilot study. J Reprod Med 50 (2005) 84-90
6. Golan A., Ron-el R., Herman A., Soffer Y., Weinraub Z., and Caspi E. Ovarian hyperstimulation syndrome. an update review. Obstet Gynecol Surv 44 (1989) 430-440
7. Al-Inany H., and Aboulghar M. GnRH antagonist in assisted reproduction. a Cochrane review. Hum Reprod 17 (2002) 874-885
8. Kolibianakis E.M., Tarlatzis B., and Devroey P. GnRH antagonists in IVF. Reprod Biomed Online 10 (2005) 705-712
9. Ludwig M., Katalinic A., and Diedrich K. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Arch Gynecol Obstet 265 (2001) 175-182
10. Ragni G., Vegetti W., Riccaboni A., Engl B., Brigante C., and Crosignani P.G. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome. Hum Reprod 20 (2005) 2421-2425
11. Hwang J.L., Seow K.M., Lin Y.H., Huang L.W., Hsieh B.C., Tsai Y.L., et al. Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome. a prospective randomized study. Hum Reprod 19 (2004) 1993-2000
12. Olivennes F., Fanchin R., Bouchard P., Taieb J., and Frydman R. Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist. Fertil Steril 66 (1996) 151-153
13. Humaidan P., Bredkjaer H.E., Bungum L., Bungum M., Grondahl M.L., Westergaard L., et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles. a prospective randomized study. Hum Reprod 20 (2005) 1213-1220
14. Kolibianakis E.M., Schultze-Mosgau A., Schroer A., van Steirteghem A., Devroey P., Diedrich K., et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 20 (2005) 2887-2892
15. Delvigne A., Carlier C., and Rozenberg S. Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle?. Fertil Steril 76 (2001) 844-846
16. Fatemi H.M., Platteau P., Albano C., Van Steirteghem A., and Devroey P. Rescue IVF and coasting with the use of a GnRH antagonist after ovulation induction. Reprod Biomed Online 5 (2002) 273-275
17. Ulug U., Bahceci M., Erden H.F., Shalev E., and Ben-Shlomo I. The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles. Hum Reprod 17 (2002) 310-313
18. Aboulghar M., Evers J.H., and Al-Inany H. Intravenous albumin for preventing severe ovarian hyperstimulation syndrome. a Cochrane review. Hum Reprod 17 (2002) 3027-3032